David J. Anderson

Person

Portage, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 12,162,890
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidine ITK inhibitors
- Patent number 11,820,775
- Issue date Nov 21, 2023
- ACLARIS THERAPEUTICS, INC.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NMDA receptor modulators and uses thereof
- Patent number 11,807,650
- Issue date Nov 7, 2023
- Novartis AG
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyridine JAK inhibitors and methods of making an...
- Patent number 11,739,086
- Issue date Aug 29, 2023
- ACLARIS THERAPEUTICS, INC.
- David Randolph Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 11,702,424
- Issue date Jul 18, 2023
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 11,648,253
- Issue date May 16, 2023
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 11,541,057
- Issue date Jan 3, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 11,542,264
- Issue date Jan 3, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolopyridines as JAK inhibitors
- Patent number 11,420,966
- Issue date Aug 23, 2022
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NMDA receptor modulators and uses thereof
- Patent number 11,274,107
- Issue date Mar 15, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 11,236,104
- Issue date Feb 1, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 11,116,749
- Issue date Sep 14, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidine ITK inhibitors
- Patent number 11,021,482
- Issue date Jun 1, 2021
- Adaris Therapeutics, Inc.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyridine JAK inhibitors and methods of making an...
- Patent number 10,981,906
- Issue date Apr 20, 2021
- ACLARIS THERAPEUTICS, INC.
- David Randolph Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 10,973,825
- Issue date Apr 13, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods...
- Patent number 10,800,775
- Issue date Oct 13, 2020
- ACLARIS THERAPEUTICS, INC.
- David Randolph Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 10,793,579
- Issue date Oct 6, 2020
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
- Patent number 10,781,174
- Issue date Sep 22, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,752,633
- Issue date Aug 25, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,626,122
- Issue date Apr 21, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 10,584,131
- Issue date Mar 10, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrimidinone NMDA receptor modulators and uses thereof
- Patent number 10,500,205
- Issue date Dec 10, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 10,329,302
- Issue date Jun 25, 2019
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
- Patent number 10,316,038
- Issue date Jun 11, 2019
- ACLARIS THERAPEUTICS, INC.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...
- Patent number 10,239,835
- Issue date Mar 26, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent number 10,052,306
- Issue date Aug 21, 2018
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-arylmethyl sulfonamide negative modulators of NR2A
- Patent number 9,963,434
- Issue date May 8, 2018
- LUC THERAPEUTICS, INC.
- David R Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 9,879,022
- Issue date Jan 30, 2018
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
- Patent number 9,540,324
- Issue date Jan 10, 2017
- LUC THERAPEUTICS, INC.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiviral compounds
- Patent number 6,852,731
- Issue date Feb 8, 2005
- Pfizer
- Scott D. Larsen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20240199617
- Publication date Jun 20, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINE ITK INHIBITORS
- Publication number 20240132505
- Publication date Apr 25, 2024
- ACLARIS THERAPEUTICS, INC.
- Eric Jon JACOBSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AN...
- Publication number 20240067643
- Publication date Feb 29, 2024
- ACLARIS THERAPEUTICS, INC.
- David Randolph ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20230339960
- Publication date Oct 26, 2023
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20230023543
- Publication date Jan 26, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
- Publication number 20230012073
- Publication date Jan 12, 2023
- Cadent Therapeutics, Inc.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS
- Publication number 20220372034
- Publication date Nov 24, 2022
- ACLARIS THERAPEUTICS, INC.
- Eric Jon Jacobsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINE ITK INHIBITORS
- Publication number 20220348579
- Publication date Nov 3, 2022
- ACLARIS THERAPEUTICS, INC.
- Eric Jon JACOBSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEUTERATED MK2 PATHWAY INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20220288070
- Publication date Sep 15, 2022
- ACLARIS THERAPEUTICS, INC.
- David Randolph ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20220274925
- Publication date Sep 1, 2022
- CADENT THERAPEUTICS, INC.
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED SULFONAMIDE PYRROLOPYRIDINES AS JAK INHIBITORS
- Publication number 20220235043
- Publication date Jul 28, 2022
- ACLARIS THERAPEUTICS, INC.
- David Randolph ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220153755
- Publication date May 19, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220047600
- Publication date Feb 17, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20220016117
- Publication date Jan 20, 2022
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20210403474
- Publication date Dec 30, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AN...
- Publication number 20210284637
- Publication date Sep 16, 2021
- ACLARIS THERAPEUTICS, INC.
- David Randolph ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20210107916
- Publication date Apr 15, 2021
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20200377511
- Publication date Dec 3, 2020
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20200369610
- Publication date Nov 26, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS
- Publication number 20200347053
- Publication date Nov 5, 2020
- ACLARIS THERAPEUTICS, INC.
- Eric Jon Jacobsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200131190
- Publication date Apr 30, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200087323
- Publication date Mar 19, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOPYRIMIDINE ITK INHIBITORS
- Publication number 20200048262
- Publication date Feb 13, 2020
- ACLARIS THERAPEUTICS, INC.
- Eric Jon JACOBSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20200039987
- Publication date Feb 6, 2020
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOPYRIMIDINE ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER
- Publication number 20190352300
- Publication date Nov 21, 2019
- ACLARIS THERAPEUTICS, INC.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20190270751
- Publication date Sep 5, 2019
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...
- Publication number 20190152912
- Publication date May 23, 2019
- Cadent Therapeutics, Inc.
- David R. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYL PYRROLO[2,3-B]PYRMIDINE-5-CARBOXYLATE ANALOGS AND METHODS...
- Publication number 20190135807
- Publication date May 9, 2019
- ACLARIS THERAPEUTICS, INC.
- David Randolph ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AN...
- Publication number 20190135808
- Publication date May 9, 2019
- ACLARIS THERAPEUTICS, INC.
- David Randolph ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20180369245
- Publication date Dec 27, 2018
- Cadent Therapeutics, Inc.
- David R. ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David J. Anderson

Person

Patents Grantslast 30 patents

Heteroaromatic NMDA receptor modulators and uses thereof

Pyrrolopyrimidine ITK inhibitors

NMDA receptor modulators and uses thereof

Substituted pyrrolopyridine JAK inhibitors and methods of making an...

Bicyclic-fused heteroaryl or aryl compounds

Thienopyrimidinone NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Substituted pyrrolopyridines as JAK inhibitors

NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Pyrrolopyrimidine ITK inhibitors

Substituted pyrrolopyridine JAK inhibitors and methods of making an...

Thienopyrimidinone NMDA receptor modulators and uses thereof

Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods...

Bicyclic-fused heteroaryl or aryl compounds

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...

Heteroaromatic NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Heteroaromatic NMDA receptor modulators and uses thereof

Thienopyrimidinone NMDA receptor modulators and uses thereof

Bicyclic-fused heteroaryl or aryl compounds

Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allos...

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

N-arylmethyl sulfonamide negative modulators of NR2A

Bicyclic-fused heteroaryl or aryl compounds

Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B

Antiviral compounds

Patents Applicationslast 30 patents

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

PYRROLOPYRIMIDINE ITK INHIBITORS

SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AN...

Bicyclic-Fused Heteroaryl or Aryl Compounds

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B

SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS

PYRROLOPYRIMIDINE ITK INHIBITORS

DEUTERATED MK2 PATHWAY INHIBITORS AND METHODS OF USING THE SAME

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

SUBSTITUTED SULFONAMIDE PYRROLOPYRIDINES AS JAK INHIBITORS

NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AN...

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

Bicyclic-Fused Heteroaryl or Aryl Compounds

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

NMDA RECEPTOR MODULATORS AND USES THEREOF

PYRROLOPYRIMIDINE ITK INHIBITORS

HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF

PYRROLOPYRIMIDINE ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER

Bicyclic-Fused Heteroaryl or Aryl Compounds

N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOS...

PYRAZOLYL PYRROLO[2,3-B]PYRMIDINE-5-CARBOXYLATE ANALOGS AND METHODS...

SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AN...

THIENOPYRIMIDINONE NMDA RECEPTOR MODULATORS AND USES THEREOF